Microarrays divide the world in to three parts. The first does not know what microarrays are. The second does, but lacks business management and stock investing skills. The third appreciates both microarrays and business. This is a Mantra for stock market success. Microarrays are not alone. All business involves technology. Technology is academic science as long as it does not serve society by generating wealth. A technological route can take investors above market turbulence.
Microarrays have already changed the face of health care. Diagnostic facilities are entirely different from the days when your physician was in medical school. Microarrays are vital in the fight against biological terrorism, and in the cause of food safety. Microarrays have decades of dividends in their folds because the business applications are nearly without limit. Human ignorance about the business potentials of microarrays is a colossal pity. It is also an immediate advantage for the discerning stock investor in the turbulence of Autumn 2008.
The pharmaceutical industry keeps Gross Margins of microarrays under tight wraps. Diagnostic laboratories are happy to follow suit. It is a mug's game for microarray costing is most sensitive to consumption volumes. Honest and capable regulators can change all that, but what is the use of wishful thinking? The action point is to use microarrays to start dynamic new enterprises. It is also a God-send opportunity for stock investment during the coming week.
Post below or write to me at drsbanerji@gmail.com to know more.
No comments:
Post a Comment